SAN ANTONIO (June 15, 2021) - The Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) ...
News
- Southwest National Primate Research Center at Texas Biomed receives $37 million NIH grant
- Alamo City research contributes to potential new Covid vaccine
Maryland-based biotech Novavax shared its findings on Monday from a Phase 3 clinical trial involving UT Health San Antonio and University Health, ...
- PetVivo Holdings, Inc. Releases Conference and Exhibit Schedule for 2021-2022
American Association of Equine Practitioners November 18-22 San Antonio, Texas ... PetVivo Holdings Inc. (OTCQB: PETV) is an emerging biomedical device company currently focused on the manufacturing, commercialization and ...
- Advaxis: Fiscal Q2 Earnings Snapshot
The biotechnology company posted revenue of $1.4 million in the period. In the final minutes of trading on Monday, the company's shares hit 50 cents. A ...
- Novavax: Large study finds COVID-19 shot about 90% effective
The two-shot vaccine was about 90% effective overall, and preliminary data showed it was safe, the American biotechnology company said.